Tom A. Back

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Spontaneous association of different forms of non-conjugated astatine-211 to serum albumin.

Spontaneous association of different forms of non-conjugated astatine-211 to serum albumin.

Journal: Nuclear medicine and biology

Published: September 12, 2025

Modified poly-L-lysine for use as a clearing agent in pretargeted radioimmunotherapy.

Modified poly-L-lysine for use as a clearing agent in pretargeted radioimmunotherapy.

Journal: EJNMMI radiopharmacy and chemistry

Published: September 09, 2024

211At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation.

211At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: January 31, 2024

In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211.

In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211.

Journal: EJNMMI radiopharmacy and chemistry

Published: January 25, 2024

A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In Vitro.

A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In Vitro.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: January 24, 2024

A proposed production method for astatinated (At-211) Trastuzumab for use in a Phase I clinical trial.

A proposed production method for astatinated (At-211) Trastuzumab for use in a Phase I clinical trial.

Journal: PloS one

Published: October 16, 2023

Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211.

Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 14, 2023

Astatine-211 based radionuclide therapy: Current clinical trial landscape.

Astatine-211 based radionuclide therapy: Current clinical trial landscape.

Journal: Frontiers in medicine

Published: October 21, 2022

Covalent core-radiolabeling of polymeric micelles with 125I/211At for theranostic radiotherapy.

Covalent core-radiolabeling of polymeric micelles with 125I/211At for theranostic radiotherapy.

Journal: Nanotheranostics

Published: February 14, 2022

Estimating the Risk for Secondary Cancer After Targeted α-Therapy with 211At Intraperitoneal Radioimmunotherapy.

Estimating the Risk for Secondary Cancer After Targeted α-Therapy with 211At Intraperitoneal Radioimmunotherapy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 08, 2021

Modeling bystander effects that cause growth delay of breast cancer xenografts in bone marrow of mice treated with radium-223.

Modeling bystander effects that cause growth delay of breast cancer xenografts in bone marrow of mice treated with radium-223.

Journal: International journal of radiation biology

Published: July 07, 2021

Radium-223-Induced Bystander Effects Cause DNA Damage and Apoptosis in Disseminated Tumor Cells in Bone Marrow.

Radium-223-Induced Bystander Effects Cause DNA Damage and Apoptosis in Disseminated Tumor Cells in Bone Marrow.

Journal: Molecular cancer research : MCR

Published: January 04, 2021

Showing 1-12 of 42

Last Updated: 09/26/2026